COMPUTED DESCRIPTORS
| Molecular Weight | 1046.3 g/mol |
|---|---|
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 31 |
| Exact Mass | 1045.57695690 g/mol |
| Monoisotopic Mass | 1045.57695690 g/mol |
| Topological Polar Surface Area | 301 Ų |
| Heavy Atom Count | 73 |
| Formal Charge | 0 |
| Complexity | 1880 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Vorsetuzumab mafodotin is under investigation in clinical trial NCT01677390 (A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma).